Home › Valeant Pharmaceuticals Intl Inc (VRX) Receives Underperform Rating from Wells Fargo
 

Keywords :   


Valeant Pharmaceuticals Intl Inc (VRX) Receives Underperform Rating from Wells Fargo

2016-04-15 22:46:50| Biotech - Topix.net

's stock had its "underperform" rating restated by research analysts at Wells Fargo in a report issued on Friday, MarketBeat.com reports. Shares of Valeant Pharmaceuticals Intl traded down 0.03% during midday trading on Friday, reaching $32.35.

Tags: rating receives wells intl

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05WCC Re-elects Tom Bowtell for Second Term as President, Recognizes Contributions of Andy Doyle
20.05May/June 2024 Digital Edition of National Hog Farmer now available
20.05DKSH Extends Distribution Agreement with KRONOS in Asia Pacific
20.05NABC hosts foreign animal disease tabletop exercise
20.05NABC hosts foreign animal disease tabletop exercise
20.05Printed Easy increases capacity by 300% with Durst
20.05Eastern North Pacific Tropical Weather Outlook
20.05Atlantic Tropical Weather Outlook
More »